UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 996

Sortiert nach

CA-180: La quantité et la densité du tissu adipeux viscéral, mesurés par tomodensitométrie, sont indépendamment associées au profil de risque cardiométabolique : résultats de l'étude internationale INSPIRE ME IAA

Diabetes & metabolism, 2016-03, Vol.42, p.A84-A84

2016

Volltextzugriff (PDF)

Storm type effects on super Clausius–Clapeyron scaling of intense rainstorm properties with air temperature

Hydrology and earth system sciences, 2015-04, Vol.19 (4), p.1753-1766

2015

Volltextzugriff (PDF)

Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future

Obesity reviews, 2017-10, Vol.18 (10), p.1136-1146

2017

Volltextzugriff (PDF)

Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population

International Journal of Obesity, 2017-11, Vol.41 (11), p.1615-1620

2017

Volltextzugriff (PDF)

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function

Diabetologia, 2011-06, Vol.54 (6), p.1273-1290

2011

Volltextzugriff (PDF)

Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options

Journal of endocrinological investigation, 2017-11, Vol.40 (11), p.1165-1174

2017

Volltextzugriff (PDF)

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Cardiovascular diabetology, 2016-02, Vol.15 (1), p.29, Article 29

2016

Volltextzugriff (PDF)

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

International Journal of Obesity, 2012-06, Vol.36 (6), p.843-854

2012

Volltextzugriff (PDF)

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

Alimentary Pharmacology & Therapeutics (Suppl), 2018-05, Vol.47 (10), p.1387-1396

2018

Volltextzugriff (PDF)

Assessing the impact of complications on the costs of Type II diabetes

Diabetologia, 2002-07, Vol.45 (7), p.S13-S17

2002

Volltextzugriff (PDF)

Dependence between flood peaks and volumes: a case study on climate and hydrological controls

Hydrological sciences journal, 2015-06, Vol.60 (6), p.968-984

2015

Volltextzugriff (PDF)

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

International Journal of Obesity, 2004-11, Vol.28 (11), p.1399-1410

2004

Volltextzugriff (PDF)

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

International Journal of Obesity, 2014-05, Vol.38 (5), p.689-697

2014

Volltextzugriff (PDF)

Obesity, haemostasis and the fibrinolytic system

Obesity reviews, 2002-05, Vol.3 (2), p.85-101

2002

Volltextzugriff (PDF)

Bayesian MCMC approach to regional flood frequency analyses involving extraordinary flood events at ungauged sites

Journal of hydrology (Amsterdam), 2010-11, Vol.394 (1-2), p.101-117

2010

Volltextzugriff (PDF)

Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance

International Journal of Obesity, 2015-03, Vol.39 (3), p.495-501

2015

Volltextzugriff (PDF)

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.523-530

2012

Volltextzugriff (PDF)

Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss

The journal of clinical endocrinology and metabolism, 2015-12, Vol.100 (12), p.4463-4471

2015

Volltextzugriff (PDF)

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

International Journal of Obesity, 2006-08, Vol.30 (8), p.1308-1314

2006

Volltextzugriff (PDF)

P65 Prise en charge des facteurs de risque cardio-vasculaire chez le patient diabétique de type 2 : comparaison de deux enquêtes observationnelles nationales à 5 années d’intervalle

Diabetes & metabolism, 2008, Vol.34, p.H62-H62

2008

Volltextzugriff (PDF)

Sarcopenia in patients with non‐alcoholic fatty liver disease: is it a clinically significant entity?

Obesity reviews, 2019-02, Vol.20 (2), p.353-363

2019

Volltextzugriff (PDF)

Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity

International Journal of Obesity, 2014-07, Vol.38 (7), p.1000-1004

2014

Volltextzugriff (PDF)

A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population

Obesity (Silver Spring, Md.), 2013-10, Vol.21 (10), p.2138-2145

2013

Volltextzugriff (PDF)

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Diabetic medicine, 2020-02, Vol.37 (2), p.256-266

2020

Volltextzugriff (PDF)

Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease

Acta diabetologica, 2021-03, Vol.58 (3), p.319-327

2021

Volltextzugriff (PDF)

1 – 25 von 996

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(827)
Mit Volltextzugriff
(807)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

CA-180: La quantité et la densité du tissu adipeux viscéral, mesurés par tomodensitométrie, sont indépendamment associées au profil de risque cardiométabolique : résultats de l'étude internationale INSPIRE ME IAA

Storm type effects on super Clausius–Clapeyron scaling of intense rainstorm properties with air temperature

Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future

Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function

Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

Assessing the impact of complications on the costs of Type II diabetes

Dependence between flood peaks and volumes: a case study on climate and hydrological controls

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

Obesity, haemostasis and the fibrinolytic system

Bayesian MCMC approach to regional flood frequency analyses involving extraordinary flood events at ungauged sites

Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

P65 Prise en charge des facteurs de risque cardio-vasculaire chez le patient diabétique de type 2 : comparaison de deux enquêtes observationnelles nationales à 5 années d’intervalle

Sarcopenia in patients with non‐alcoholic fatty liver disease: is it a clinically significant entity?

Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity

A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease

Suchergebnisse filtern